We serve Chemical Name:3,6-Dibromo-2-pyrazinecarboxamide CAS:1301613-77-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,6-Dibromo-2-pyrazinecarboxamide
CAS.NO:1301613-77-3
Synonyms:3,6-Dibromo-2-pyrazinecarboxamide;2-Pyrazinecarboxamide, 3,6-dibromo-
Molecular Formula:C5H3Br2N3O
Molecular Weight:280.905
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:323.4±42.0 °C at 760 mmHg
Density:2.2±0.1 g/cm3
Index of Refraction:1.658
PSA:69.86000
Exact Mass:278.864258
LogP:1.13
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3,6-Dibromo-2-pyrazinecarboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyrazinecarboxamide, 3,6-dibromo- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyrazinecarboxamide, 3,6-dibromo- Use and application,2-Pyrazinecarboxamide, 3,6-dibromo- technical grade,usp/ep/jp grade.
Related News: Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 3,6-Dibromo-2-pyrazinecarboxamide manufacturer With the structural upgrade of the pharmaceutical industry in developed countries, the transfer of related industrial chains has taken place globally, and it has also had a profound impact on Chinese pharmaceutical companies. near 3,6-Dibromo-2-pyrazinecarboxamide supplier Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country. 3,6-Dibromo-2-pyrazinecarboxamide vendor Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 3,6-Dibromo-2-pyrazinecarboxamide factory Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology.
